![Jeffrey Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Jones
Chief Tech/Sci/R&D Officer at CULLINAN THERAPEUTICS, INC.
Net worth: 321 739 $ as of 2024-05-30
Jeffrey Jones active positions
Companies | Position | Start | End |
---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-27 | - |
Career history of Jeffrey Jones
Former positions of Jeffrey Jones
Companies | Position | Start | End |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 2017-07-31 | 2020-03-31 |
Corporate Officer/Principal | 2020-03-31 | 2022-01-31 | |
The Ohio State University College of Medicine | Corporate Officer/Principal | - | - |
Cullinan Oncology LLC
![]() Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2022-01-31 | - |
Training of Jeffrey Jones
University of Michigan Medical School | Doctorate Degree |
Fisher College of Business | Masters Business Admin |
The University of Texas Health Science Center at Houston | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 5 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CULLINAN THERAPEUTICS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 1 |
---|---|
Cullinan Oncology LLC
![]() Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Stock Market
- Insiders
- Jeffrey Jones
- Experience